BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1322549)

  • 1. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate.
    Motohashi N
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):571-9. PubMed ID: 1322549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?
    Motohashi N; Ikawa K; Kariya T
    Eur J Pharmacol; 1989 Jul; 166(1):95-9. PubMed ID: 2553432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation.
    Lee WS; Limmroth V; Ayata C; Cutrer FM; Waeber C; Yu X; Moskowitz MA
    Br J Pharmacol; 1995 Sep; 116(1):1661-7. PubMed ID: 8564234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.
    Egashira N; Abe M; Shirakawa A; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Psychopharmacology (Berl); 2013 Mar; 226(2):295-305. PubMed ID: 23086022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation by chlormethiazole of the GABAA-receptor complex in rat brain.
    Cross AJ; Stirling JM; Robinson TN; Bowen DM; Francis PT; Green AR
    Br J Pharmacol; 1989 Sep; 98(1):284-90. PubMed ID: 2553191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of agonists and antagonists at the GABA/benzodiazepine receptor on conditioned suppression in rats.
    Shephard RA; Toal L; Leslie JC
    Pharmacol Biochem Behav; 1990 May; 36(1):39-43. PubMed ID: 2161544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes.
    Bowery NG; Hill DR; Hudson AL
    Br J Pharmacol; 1983 Jan; 78(1):191-206. PubMed ID: 6297646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.
    Ulrich ML; Rotzinger S; Asghar SJ; Jurasz P; Tanay VA; Dunn SM; Radomski M; Greenshaw A; Silverstone PH
    J Psychiatry Neurosci; 2003 Mar; 28(2):115-25. PubMed ID: 12670128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
    Cui J; Shao L; Young LT; Wang JF
    Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAB receptor-mediated inhibition of histamine H1-receptor-induced inositol phosphate formation in slices of rat cerebral cortex.
    Crawford ML; Young JM
    J Neurochem; 1988 Nov; 51(5):1441-7. PubMed ID: 2844993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1999 Feb; 141(4):370-7. PubMed ID: 10090644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids.
    O'Donnell T; Rotzinger S; Ulrich M; Hanstock CC; Nakashima TT; Silverstone PH
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):220-7. PubMed ID: 12888180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Baumann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar; 337(3):289-95. PubMed ID: 2839779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAB autoreceptors in rat cortex synaptosomes: response under different depolarizing and ionic conditions.
    Bonanno G; Pellegrini G; Asaro D; Fontana G; Raiteri M
    Eur J Pharmacol; 1989 Mar; 172(1):41-9. PubMed ID: 2540998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
    Raiteri M; Bonanno G; Fedele E
    J Pharmacol Exp Ther; 1989 Aug; 250(2):648-53. PubMed ID: 2547942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro.
    Olpe HR; Steinmann MW; Pozza MF; Brugger F; Schmutz M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):655-7. PubMed ID: 2854215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.
    Mann L; Heldman E; Bersudsky Y; Vatner SF; Ishikawa Y; Almog O; Belmaker RH; Agam G
    Bipolar Disord; 2009 Dec; 11(8):885-96. PubMed ID: 19922557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
    Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
    Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.